Economic burden of cancer does not stop after treatment

the ONA take:

According to a new study released online and being presented at the upcoming ASCO Annual Meeting in Chicago, IL, researchers have found that the economic burden of cancer extends into survivorship.

Specifically, cancer survivors deal with excess medical expenses, employment disability, and reduced production at work.

For the study, researchers analyzed the economic burden among elderly and nonelderly survivors with breast, colorectal, and prostate cancer in the United States using data from the Medical Expenditure Panel Survey between 2008 and 2012.

Researchers identified 1,568 female breast cancer survivors, 540 colorectal cancer survivors, and 1,170 prostate cancer survivors and compared their expenditures, productivity loss at work, and productivity loss at home to 100,000 people without a cancer history.

Results showed that elderly and nonelderly patients had between $9,278 and $20,238 of total annual economic burden depending on cancer type.

Nonelderly survivors of breast and colorectal cancer lost 3 and 7 days worth of productivity at work, respectively, and 3 and 5 days worth of productivity at home, respectively.

Economic burden of cancer does not stop after treatment
The economic burden of cancer extends into survivorship
Researchers led by Zhiyuan "Jason" Zheng examined the economic burden among survivors of the three most prevalent cancers (colorectal, female breast, and prostate) in nonelderly and elderly populations in the United States, using 2008 to 2012 Medical Expenditure Panel Survey data.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs